Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-03-10FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for TRINTELLIX (vortioxetine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Improving Heart Health in Appalachia [NA]
This clinical trial update notes the completion of a study aimed at improving heart health in Appalachian populations, focusing on obesity, …
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy [NA]
A completed clinical trial comparing yoga or educational wellness for women with breast cancer undergoing chemotherapy; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
A Massachusetts General Hospital trial evaluating brain network activation analysis as a diagnostic tool for Major Depressive Disorder has b…
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Intranasal Ketamine for Late-Life Depression and Suicidal Ideation [Phase 4]
A Phase 4 clinical trial evaluating intranasal esketamine for late-life depression and suicidal ideation has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine [Phase 1]
Phase 1 clinical trial update evaluating whether cognitive behavioral therapy can prolong the antidepressant effects of intravenous ketamine…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression [NA]
A completed clinical trial evaluating predictors of treatment outcome for cognitive behavioral therapy in major depressive disorder; results…
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Rhythm and Depression [NA]
This clinical trial update involves depression and is sponsored by Centre Hospitalier Universitaire de Besancon; the current status is UNKNO…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder [Phase 3]
A Phase 3 trial compared vortioxetine with escitalopram to assess cognitive function in adults with major depressive disorder who inadequate…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial update evaluating the efficacy of vortioxetine on cognitive dysfunction in working adults with major depressive disor…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Treatment for Depression Among HIV-Infected Youth [NA]
Clinical trial by University of North Carolina Chapel Hill studying treatment for depression among HIV-infected youth has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects [NA]
This clinical trial update reports the results of a terminated study examining physiological and cognitive biomarkers linked to ketamine's a…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence [Phase 2]
Phase 2 trial evaluating low-dose naltrexone for relapse prevention in adults with major depressive disorder; the study completed and posted…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks [Phase 3]
Phase 3 trial evaluating the combination of ketamine injection and venlafaxine for six weeks in adults with major depressive disorder; the s…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Study of NSI-189 for Major Depressive Disorder [Phase 2]
Phase 2 clinical trial update for NSI-189 in Major Depressive Disorder; the current status of the study is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes [NA]
This completed clinical trial evaluated mindfulness-based personalized health planning to reduce the risk of heart disease and diabetes in a…
-
FDA approval · 2017-02-23FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP, updating or expanding its labeling…
-
FDA approval · 2017-02-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc. The approval updates th…
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for aripiprazole, enabling the generic version to be marketed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors [NA]
The clinical trial evaluating Ecosystem Focused Therapy for older ischemic stroke survivors with depression has completed.
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer [NA]
A completed clinical trial update reporting on a health-promotion study for patients with early-stage breast or prostate cancer, including c…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Depression Treatment for Low Income Substance Users [NA]
The clinical trial evaluating depression treatment for low-income individuals with substance use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Treatment for Depressed Primary Care Patients [NA]
Completed clinical trial update evaluating treatment for depression in primary care patients. The study was conducted by Weill Medical Colle…
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application to authorize a generic aripiprazole product by Lannett Company, Inc. under ANDA204171.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Psychotherapy for Late Life Depression [NA]
This clinical trial update notes that a study evaluating psychotherapy for depression in older adults has completed. No efficacy results are…